Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

COX-2

  • You have access
    A Standardized Extract of Cultured Lentinula edodes mycelia Up-regulates COX-2 in Inflammation-related Malignant Progressive Fibrosarcoma Cell Clone QRsP-11
    TAKAO KITAGAWA, SHAJEDUL ISLAM, BYRON BARON, KAZUHIRO TOKUDA, DURGA PAUDEL, TOHRU OHTA, KOJI NAKAGAWA, MASANOBU KOBAYASHI, FUTOSHI OKADA and YASUHIRO KURAMITSU
    Anticancer Research March 2023, 43 (3) 1239-1244; DOI: https://doi.org/10.21873/anticanres.16270
  • Open Access
    COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells
    JUYEONG PARK, JOO YEON JEONG and SANG SOO KANG
    Anticancer Research December 2022, 42 (12) 5773-5781; DOI: https://doi.org/10.21873/anticanres.16084
  • You have access
    Bidirectional Regulation of COX-2 Expression Between Cancer Cells and Macrophages
    MARIA ISABEL CARVALHO, RODOLFO BIANCHINI, JUDIT FAZEKAS-SINGER, INA HERRMANN, IRENE FLICKINGER, JOHANN G. THALHAMMER, ISABEL PIRES, ERIKA JENSEN-JAROLIM and FELISBINA L. QUEIROGA
    Anticancer Research May 2018, 38 (5) 2811-2817;
  • You have access
    Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition
    JONG SEUNG LIM, YUJIN PARK, BYUNG MU LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research October 2016, 36 (10) 5063-5070;
  • You have access
    Positive Interplay Between CD3+ T-lymphocytes and Concurrent COX-2/EGFR Expression in Canine Malignant Mammary Tumors
    MARIA ISABEL CARVALHO, ISABEL PIRES, JUSTINA PRADA, ADRIANO FERNANDES FERREIRA and FELISBINA L. QUEIROGA
    Anticancer Research May 2015, 35 (5) 2915-2920;
  • You have access
    Evaluation of the Contribution of Cyclooxygenase 2 Genotypes to Breast Cancer in Taiwan
    CHEN-HSIEN SU, CHIEH-LUN HSIAO, WEN-SHIN CHANG, LIANG-CHIH LIU, HWEI-CHUNG WANG, CHIA-WEN TSAI, LONG-YUAN LI, CHANG-HAI TSAI and DA-TIAN BAU
    Anticancer Research November 2014, 34 (11) 6711-6716;
  • You have access
    LLW-3-6 and Celecoxib Impacts Growth in Prostate Cancer Cells and Subcellular Localization of COX-2
    TOKUNBO YEROKUN and LEYTE L. WINFIELD
    Anticancer Research September 2014, 34 (9) 4755-4759;
  • You have access
    Associations of Cyclooxygenase 2 Polymorphic Genotypes with Bladder Cancer Risk in Taiwan
    WEN-SHIN CHANG, CHIA-WEN TSAI, HONG-XUE JI, HSI-CHIN WU, YI-TING CHANG, CHI-SHUN LIEN, WEN-LING LIAO, WU-CHUNG SHEN, CHANG-HAI TSAI and DA-TIAN BAU
    Anticancer Research December 2013, 33 (12) 5401-5405;
  • You have access
    COX-2 Overexpression Induced by Gene Transfer Reduces Sensitivity of TE13 Esophageal Carcinoma Cells to 5-Fluorouracil and Cisplatin
    HIROKO OKAMURA, HITOSHI FUJIWARA, SEIJI UMEHARA, SHINICHI OKAMURA, MOMOKO TODO, AKINOBU FURUTANI, MASAYUKI YONEDA, ATSUSHI SHIOZAKI, SHUHEI KOMATSU, TAKESHI KUBOTA, DAISUKE ICHIKAWA, KAZUMA OKAMOTO, TOSHIYA OCHIAI, CHOUHEI SAKAKURA, YOSHITAKA TAKAHASHI, TANIHIRO YOSHIMOTO and EIGO OTSUJI
    Anticancer Research February 2013, 33 (2) 537-542;
  • You have access
    Biomarkers of Pituitary Neoplasms
    AYDIN SAV, FABIO ROTONDO, LUIS V. SYRO, BERND W. SCHEITHAUER and KALMAN KOVACS
    Anticancer Research November 2012, 32 (11) 4639-4654;
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire